New test predicts blood cancer’s sensitivity to experimental cancer drug



A test developed by Dana-Farber Cancer Institute scientists is the first to identify which malignant blood cells are highly vulnerable to a promising type of experimental drugs that unleash pent-up “cell suicide” factors to destroy the cancer.

(Read the rest of this article …)

Related Posts with Thumbnails
Print Friendly

Speak Your Mind

*


*

NOTE: The contents in this blog are for informational purposes only, and should not be construed as medical advice, diagnosis, treatment or a substitute for professional care. Always seek the advice of your physician or other qualified health professional before making changes to any existing treatment or program. Some of the information presented in this blog may already be out of date.
Read previous post:
Radiation Therapy for Breast Cancer: Coping with Skin Reactions

By Carol Kornmehl Radiation therapy is a simple, painless, and generally well-tolerated tool for treating and even curing breast cancer....

Close